Received Mar 9, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MENB | MENINGOCOCCAL B (BEXSERO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | — | — |
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | — | — |
vaccines involved were: MENVEO one vial and BEXSERO. Temperature/time: thirteen point twenty-three degrees Celsius/fours hours forty five minutes. No prior temperature excursions reported. The Medical Doctor-Pediatrician did not have notice of this i; This non-serious case was reported by a physician via call center representative and described the occurrence of incorrect storage of drug in a patient who received Men ACWY-CRM NVS (Menveo) for prophylaxis. Co-suspect products included Men B NVS (Bexsero) for prophylaxis. On an unknown date, the patient received Menveo and Bexsero. On an unknown date, an unknown time after receiving Menveo and Bexsero, the patient experienced incorrect storage of drug (Verbatim: vaccines involved were: MENVEO one vial and BEXSERO. Temperature/time: thirteen point twenty-three degrees Celsius/fours hours forty five minutes. No prior temperature excursions reported. The Medical Doctor-Pediatrician did not have notice of this i). The outcome of the incorrect storage of drug was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 27-FEB-2026 The vaccines involved were one vial of MENVEO and BEXSERO. The recorded temperature during the incident was thirteen point twenty-three degrees Celsius for four hours and forty-five minutes. No prior temperature excursions were reported. The medical doctor and pediatrician did not have notice of this incident. The medical doctor and pediatrician inadvertently administered the vaccines to a patient. The batch number was not provided upon follow up with the reporter